Enregistré dans:
Détails bibliographiques
Auteurs principaux: Lu, Yiwen, Li, Lu, Zhang, Dazheng, Jian, Xinyao, Wang, Tingyin, Chen, Siqi, Lei, Yuqing, Tong, Jiayi, Xi, Zhaohan, Chu, Haitao, Luo, Chongliang, Ogdie, Alexis, Athey, Brian, Turan, Alparslan, Abramoff, Michael, Cappelleri, Joseph C, Xu, Hua, Lu, Yun, Berlin, Jesse, Sessler, Daniel I., Asch, David A., Jiang, Xiaoqian, Chen, Yong
Format: Preprint
Publié: 2025
Sujets:
Accès en ligne:https://arxiv.org/abs/2509.12471
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
_version_ 1866916950939009024
author Lu, Yiwen
Li, Lu
Zhang, Dazheng
Jian, Xinyao
Wang, Tingyin
Chen, Siqi
Lei, Yuqing
Tong, Jiayi
Xi, Zhaohan
Chu, Haitao
Luo, Chongliang
Ogdie, Alexis
Athey, Brian
Turan, Alparslan
Abramoff, Michael
Cappelleri, Joseph C
Xu, Hua
Lu, Yun
Berlin, Jesse
Sessler, Daniel I.
Asch, David A.
Jiang, Xiaoqian
Chen, Yong
author_facet Lu, Yiwen
Li, Lu
Zhang, Dazheng
Jian, Xinyao
Wang, Tingyin
Chen, Siqi
Lei, Yuqing
Tong, Jiayi
Xi, Zhaohan
Chu, Haitao
Luo, Chongliang
Ogdie, Alexis
Athey, Brian
Turan, Alparslan
Abramoff, Michael
Cappelleri, Joseph C
Xu, Hua
Lu, Yun
Berlin, Jesse
Sessler, Daniel I.
Asch, David A.
Jiang, Xiaoqian
Chen, Yong
contents Sample size calculations for power analysis are critical for clinical research and trial design, yet their complexity and reliance on statistical expertise create barriers for many researchers. We introduce PowerGPT, an AI-powered system integrating large language models (LLMs) with statistical engines to automate test selection and sample size estimation in trial design. In a randomized trial to evaluate its effectiveness, PowerGPT significantly improved task completion rates (99.3% vs. 88.9% for test selection, 99.3% vs. 77.8% for sample size calculation) and accuracy (94.1% vs. 55.4% in sample size estimation, p < 0.001), while reducing average completion time (4.0 vs. 9.3 minutes, p < 0.001). These gains were consistent across various statistical tests and benefited both statisticians and non-statisticians as well as bridging expertise gaps. Already under deployment across multiple institutions, PowerGPT represents a scalable AI-driven approach that enhances accessibility, efficiency, and accuracy in statistical power analysis for clinical research.
format Preprint
id arxiv_https___arxiv_org_abs_2509_12471
institution arXiv
publishDate 2025
record_format arxiv
spellingShingle Empowering Clinical Trial Design through AI: A Randomized Evaluation of PowerGPT
Lu, Yiwen
Li, Lu
Zhang, Dazheng
Jian, Xinyao
Wang, Tingyin
Chen, Siqi
Lei, Yuqing
Tong, Jiayi
Xi, Zhaohan
Chu, Haitao
Luo, Chongliang
Ogdie, Alexis
Athey, Brian
Turan, Alparslan
Abramoff, Michael
Cappelleri, Joseph C
Xu, Hua
Lu, Yun
Berlin, Jesse
Sessler, Daniel I.
Asch, David A.
Jiang, Xiaoqian
Chen, Yong
Artificial Intelligence
Sample size calculations for power analysis are critical for clinical research and trial design, yet their complexity and reliance on statistical expertise create barriers for many researchers. We introduce PowerGPT, an AI-powered system integrating large language models (LLMs) with statistical engines to automate test selection and sample size estimation in trial design. In a randomized trial to evaluate its effectiveness, PowerGPT significantly improved task completion rates (99.3% vs. 88.9% for test selection, 99.3% vs. 77.8% for sample size calculation) and accuracy (94.1% vs. 55.4% in sample size estimation, p < 0.001), while reducing average completion time (4.0 vs. 9.3 minutes, p < 0.001). These gains were consistent across various statistical tests and benefited both statisticians and non-statisticians as well as bridging expertise gaps. Already under deployment across multiple institutions, PowerGPT represents a scalable AI-driven approach that enhances accessibility, efficiency, and accuracy in statistical power analysis for clinical research.
title Empowering Clinical Trial Design through AI: A Randomized Evaluation of PowerGPT
topic Artificial Intelligence
url https://arxiv.org/abs/2509.12471